: External Shunt Versus Internal Shunt for Off Pump Glenn

Sponsor
Kasr El Aini Hospital (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05294718
Collaborator
(none)
30
1
2
62
0.5

Study Details

Study Description

Brief Summary

A prospective, randomized comparative study where investigators present results of off pump bidirectional Glenn operation done using either a venoatrial shunt or external shunt to decompress superior vena cava during clamping.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Internal shunt
  • Procedure: External shunt
N/A

Detailed Description

The bidirectional Glenn shunt (BDG) is performed for cyanotic congenital heart defects, with single-ventricle pathology . The BDG is usually performed with cardiopulmonary bypass (CPB) with its associated complications. The conduct of this operation without CPB can be associated with elevation of superior vena caval (SVC) pressure that may lead to neurological damage.

However, the safety of performing BDG without CPB reported by many authors but with some decompression techniques of the SVC at the time of clamping

Objective: investigators present results of off pump bidirectional Glenn operation done using either a venoatrial shunt or external shunt to decompress superior vena cava during clamping.

Design A prospective, randomized comparative study Setting: Single tertiary care cardiac center Participants 30 patients with functional single ventricle who will go off pump bidirectional Glenn.

Interventions: The patients will be randomly assigned into two groups: Group I (n = 15), where it will be done with a veno-atrial shunt(internal), and Group II (n = 15), where it will be done with an external shunt. All patients will go a complete neurological examination both preoperatively as well as postoperatively Intraoperative data will be collected and analyzed at the following time points: pre-clamping (post induction), during clamping and after de-clamping of SVC. variables such as arterial oxygen saturation (SaO2), systolic blood pressure (SBP), mean arterial blood pressure (MAP), diastolic blood pressure (DBP), and hematocrit, CVP, SVC pressure, cerebral perfusion pressure (CPP= MAP-CVP), PaO2, PaCO2 and ScvO2 will be analyzed.

Postoperatively, the patients will be stabilized in the intensive care unit (ICU) and after monitoring the SVC pressure for 12 h, the internal jugular vein cannula will be removed to prevent any jugular vein thrombosis. The patients will start aspirin (5 mg/kg/day), which will be continued indefinitely.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
A prospective, randomized comparative studyA prospective, randomized comparative study
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description:
concealed in opaque closed envelops
Primary Purpose:
Treatment
Official Title:
External Shunt Versus Internal Shunt for Off Pump Glenn (Original Article)
Actual Study Start Date :
Jun 1, 2017
Anticipated Primary Completion Date :
May 1, 2022
Anticipated Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Internal shunt

glenn with internal shunt (veno-atrial shunt) where the surgeon established a shunt between distal SVC and the right atrium, Establishing a veno-atrial shunt.

Procedure: Internal shunt
glenn with internal shunt (veno-atrial shunt) where the surgeon established a shunt between distal SVC and the right atrium, Establishing a veno-atrial shunt.
Other Names:
  • Venoatrial shunt
  • Active Comparator: External shunt

    Glenn with external shunt where the anesthesiologist connected the internal Jagular venous cannula which represent the SVC with the main lumen of the femoral cannula which represent the IVC through long venous extension

    Procedure: External shunt
    Glenn with external shunt where the anesthesiologist connected the internal Jagular venous cannula which represent the SVC with the main lumen of the femoral cannula which represent the IVC through long venous extension
    Other Names:
  • Jagulo femoral shunt
  • Outcome Measures

    Primary Outcome Measures

    1. Mean SVC Pressure [during SVC clamping procedure]

      Measurment of superior vena cava pressure during off pumb Glenn

    Secondary Outcome Measures

    1. mean ABP ["baseline, pre-intervention" "during the intervention procedure" "immediately after the intervention]

      Measurment of mean arterial blood preassure during off bumb Glenn

    2. cerebral perfusion pressure ["baseline, pre-intervention" "during the intervention procedure" "immediately after the intervention]

      CPP= MABP - CVP

    3. Mean SVC clamp time [during SVC clamping procedure]

      Duration of SVC during off pump glenn with either Internal or external shunt

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    6 Months to 5 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • single-ventricle lesions,

    • good sized branch pulmonary arteries (Magoon's index > 1.5),

    • PA pressures < 20 mmHg,

    • So2 < 80%,

    • age range from (6 months-5years)

    • weight range from (6-21) kg, -All these patients had adequate atrial septal defects and none of these patients required any intra cardiac repair.-

    Exclusion Criteria:
    • previous cardiac operation,

    • known intracranial pathology,

    • neurologic disease

    • craniofacial anomalies.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Kasr Alainy hospital Cairo Egypt

    Sponsors and Collaborators

    • Kasr El Aini Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Ahmed Mohamed Mohamed Elhaddad, Lecturer of Anesthesia, ICU and Pain managment, Kasr El Aini Hospital
    ClinicalTrials.gov Identifier:
    NCT05294718
    Other Study ID Numbers:
    • MS-103-2013
    First Posted:
    Mar 24, 2022
    Last Update Posted:
    Mar 24, 2022
    Last Verified:
    Mar 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 24, 2022